Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

<ul><li>CVS Group’s agile operating model and resilient supply chain contributed to robust quarterly performance and the company managed to exceed Wall Street expectations in terms of revenues as well as earnings.</li><li>The Medicare business of the company remains a strong growth segment, and it has increased its membership across all Medicare products.</li><li>The retail script growth trend of CVS is remarkable as there has been a consistent increase in the market share.</li></ul>

CVS Group’s agile operating model and resilient supply chain contributed to robust quarterly performance and the company managed to exceed Wall Street expectations in terms of revenues as well as earnings.The Medicare business of the company remains a strong growth segment, and it has increased its membership across all Medicare products.The retail script growth trend of CVS is remarkable as there has been a consistent increase in the market share.

CVS Group: Growth Strategy & Cost Advantage

SPAC Deep Dive, subSPAC

subSPAC

SPAC Deep Dive

Each week we’ll identify and break down for you SPACs that are capturing market share and making an impact.

<ul><li>One trend that has accelerated in the last few quarters is the pace of acquisitions being made by cash-rich companies.</li><li>The significant Macroeconomic uncertainties that lie ahead, coupled with record cash balances at the largest firms on Wall Street, have only accelerated the pace of industry consolidation.</li><li>It's no secret that high-quality De-SPACs with strong earnings have been prime takeover/acquisition targets in recent months after seeing their shares take a beating through the year.</li></ul>

One trend that has accelerated in the last few quarters is the pace of acquisitions being made by cash-rich companies.The significant Macroeconomic uncertainties that lie ahead, coupled with record cash balances at the largest firms on Wall Street, have only accelerated the pace of industry consolidation.It's no secret that high-quality De-SPACs with strong earnings have been prime takeover/acquisition targets in recent months after seeing their shares take a beating through the year.

Asset Allocation & Fund Positioning, Copley Fund Research

Steven Holden

Asset Allocation & Fund Positioning

Copley Fund Research

Copley Fund Research provide research and data on asset allocation among Global and Emerging Market equity funds.  The analysis details absolute and relative positioning across countries, sectors and industries together with highly granular data on single stock and single fund allocations.  The data is updated monthly with time series going back to January 2011.

Global Research - Analysis of 165 prominent Global equity funds, combined AUM $335bn
GEM Research - Analysis of 127 prominent global EM equity funds, combined AUM $250bn

Asset Allocation - Global and GEM Equity

Thematic (Sector/Industry)

<ul>
<li>US Value funds rotate in to Health Care, pushing allocations to their highest levels on record.</li>
<li>The average Health Care allocation stands at 18.25%, with 71.4% of Value managers overweight at +3.11% above benchmark.  Health Care has become <strong>the</strong> conviction sector holding among US Value managers.</li>
<li>The most widely held stocks in the sector are Cigna Corp and Unitedhealth Group, owned by 55.7% and 52.9% of Value managers respectively.</li>
</ul>


US Value funds rotate in to Health Care, pushing allocations to their highest levels on record.
The average Health Care allocation stands at 18.25%, with 71.4% of Value managers overweight at +3.11% above benchmark.  Health Care has become the conviction sector holding among US Value managers.
The most widely held stocks in the sector are Cigna Corp and Unitedhealth Group, owned by 55.7% and 52.9% of Value managers respectively.


Credit

<ul><li>CVS Health has managed to outperform the management's financial targets and has capitalized on the pandemic situation to the best of its ability.</li><li>Its pharmacy services segment revenues increased 8.2% year over year in 2021, owing to increased pharmacy claims volume, specialty pharmacy growth, and brand inflation, partially offset by the impact of continued client price improvements.</li><li>Baptista Research looks to evaluate the different credit strengths and credit risks of the company as well as a line-by-line analysis of the financial statements of the company for the past four years.</li></ul>

CVS Health has managed to outperform the management's financial targets and has capitalized on the pandemic situation to the best of its ability.Its pharmacy services segment revenues increased 8.2% year over year in 2021, owing to increased pharmacy claims volume, specialty pharmacy growth, and brand inflation, partially offset by the impact of continued client price improvements.Baptista Research looks to evaluate the different credit strengths and credit risks of the company as well as a line-by-line analysis of the financial statements of the company for the past four years.

CVS Health: Detailed Credit Analysis & Financial Strength Evaluation Report

Equity Capital Markets

Walgreens Boots Alliance / Equity Capital Markets

<ul><li>CVS Health and Walgreens Boots Alliance are two of the largest pharmacy chains in the world.</li><li>Both these companies have done their fair share of diversification with CVS Health venturing into clinics and telehealth whereas Walgreens ventured into the cosmetics retail and other domains.</li><li>The retail space is traditionally known to have low revenue multiples and both these companies are no exceptions to this rule.</li></ul>

CVS Health and Walgreens Boots Alliance are two of the largest pharmacy chains in the world.Both these companies have done their fair share of diversification with CVS Health venturing into clinics and telehealth whereas Walgreens ventured into the cosmetics retail and other domains.The retail space is traditionally known to have low revenue multiples and both these companies are no exceptions to this rule.

CVS Health vs. Walgreens Boots Alliance - The Battle Of The Pharmacy Majors

United States

CVS Health Corporation is an integrated pharmacy health care provider. The Company's offerings include pharmacy benefit management services; mail order, retail and specialty pharmacy; disease management programs; and retail clinics. The company operates drugstores throughout the U.S., the District of Columbia, and Puerto Rico.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Cvs Health Corp (CVS US)

CVS Group: Growth Strategy & Cost Advantage

CVS Group’s agile operating model and resilient supply chain contributed to robust quarterly performance and the company managed to exceed Wall...

Baptista Research

Reinventing American Healthcare

The significant Macroeconomic uncertainties that lie ahead, coupled with record cash balances at the largest firms on Wall Street, have only...

subSPAC

US Value Funds Rotate in to Health Care

US Value managers have made an active rotation in to the Health Care sector, pushing allocations to their highest levels on record.

Steven Holden

CVS Health: Detailed Credit Analysis & Financial Strength Evaluation Report

CVS Health has managed to outperform the management's financial targets and has capitalized on the pandemic situation to the best of its...

Baptista Research

CVS Health vs. Walgreens Boots Alliance - The Battle Of The Pharmacy Majors

CVS Health and Walgreens Boots Alliance are two of the largest pharmacy chains in the world. Both these companies have done their fair share of...

Baptista Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)